Hearing Loss: When to See a Doctor and What Causes It

How Common Is Hearing Loss and Why Does It Matter

Hearing loss is the third most common chronic physical condition in adults in the United States, trailing only arthritis and heart disease. The World Health Organization estimates that 1.5 billion people globally have some degree of hearing loss, and that figure is projected to rise to 2.5 billion by 2050. By age 75, roughly half of all Americans have hearing loss significant enough to affect daily communication.

The Cognitive Connection

Unaddressed hearing loss carries consequences beyond the auditory system. A landmark longitudinal study by Lin et al. Published in the Archives of Neurology followed 639 adults over 12 years and found that moderate hearing loss tripled the risk of incident dementia, independent of age, sex, race, education, and cardiovascular risk factors. The biological mechanism likely involves increased cognitive load, auditory deprivation, and accelerated cortical reorganization.

Social and Economic Burden

Untreated hearing loss is also associated with depression, social withdrawal, reduced workplace productivity, and increased accident risk. The CDC estimates that noise-induced hearing loss alone costs the U.S. Economy approximately $242 million annually in direct healthcare expenditures, not counting lost wages or quality-of-life measures.

What Causes Hearing Loss

The causes divide cleanly into two anatomical categories: conductive (something blocking or damaging sound transmission through the outer or middle ear) and sensorineural (damage to the cochlea, auditory nerve, or central auditory pathways). A third category, mixed loss, combines both.

Sensorineural Causes

Sensorineural hearing loss (SNHL) is the most common type in adults and is usually permanent.

Presbycusis (age-related loss): Hair cells in the cochlea degenerate progressively starting in the high frequencies. By age 65, approximately 33% of adults have clinically significant SNHL. By age 75, that figure reaches roughly 50%, according to NIDCD data.

Noise-induced hearing loss (NIHL): Exposure to sounds at or above 85 dB for extended periods destroys outer hair cells permanently. A study in Occupational and Environmental Medicine showed that workers exposed to 90 dB for 10 years had a fourfold higher rate of significant SNHL compared to non-exposed controls. Recreational sources including concerts, power tools, and earbuds at high volume carry identical risk.

Sudden sensorineural hearing loss: Defined as 30 dB or more of loss across three contiguous frequencies developing over 72 hours or less, SSNHL affects approximately 5 to 27 per 100,000 people per year. A viral etiology is presumed in most idiopathic cases, though autoimmune, vascular, and perilymphatic fistula etiologies account for a subset. About 32 to 65% of patients recover partial or full hearing spontaneously, but corticosteroid treatment within two weeks substantially improves those odds.

Ototoxic medications: Aminoglycoside antibiotics (gentamicin, tobramycin), cisplatin-based chemotherapy, loop diuretics at high doses, and quinine-class antimalarials all carry cochleotoxic risk. Cisplatin-associated SNHL occurs in 40 to 80% of patients depending on cumulative dose and concurrent noise exposure.

Meniere's disease: Endolymphatic hydrops produces episodic vertigo lasting 20 minutes to 12 hours, fluctuating low-frequency SNHL, tinnitus, and aural fullness. The four-symptom tetrad distinguishes it from benign positional vertigo.

Conductive Causes

Conductive losses are frequently reversible once the underlying blockage or structural problem is corrected.

Cerumen impaction: The most common reversible cause. Occlusive earwax blocks the ear canal and can reduce hearing by 35 to 40 dB. Manual removal or irrigation restores normal thresholds immediately.

Otitis media with effusion (OME): Fluid in the middle ear space without acute infection is common in children and occurs in adults following barotrauma or Eustachian tube dysfunction. Thresholds typically return to baseline once fluid resolves.

Otosclerosis: Abnormal bony remodeling around the stapes footplate reduces ossicular mobility. It affects roughly 0.3% of the population, more commonly in White women, and is treated with stapedectomy or stapedotomy, which restores hearing in over 90% of carefully selected patients.

Tympanic membrane perforation: Traumatic rupture from a cotton swab, blast injury, or untreated acute otitis media causes conductive loss proportional to perforation size. Most small perforations (under 25% of membrane area) heal spontaneously within 3 months.

When Hearing Loss Is a Medical Emergency

Speed matters dramatically for certain presentations. The following signs should prompt same-day evaluation at an emergency department or otolaryngology clinic.

Sudden Onset Within 72 Hours

Any hearing loss that developed over three days or less is sudden sensorineural hearing loss until proven otherwise. The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) 2019 Clinical Practice Guideline states: "Clinicians should distinguish sensorineural hearing loss from conductive hearing loss in a patient presenting with sudden hearing loss." Do not wait days to see a primary care provider. Corticosteroid treatment is time-sensitive: the therapeutic window closes at approximately two weeks from symptom onset.

Hearing Loss with Neurological Symptoms

Hearing loss accompanied by any of the following requires emergency imaging (MRI brain with and without gadolinium or CT temporal bones) and same-day evaluation:

• Unilateral facial weakness or numbness
• Sudden severe headache described as "the worst of my life"
• Double vision or other cranial nerve findings
• Dysarthria or dysphasia
• New or rapidly worsening tinnitus in only one ear

These combinations may indicate a cerebellopontine angle tumor (acoustic neuroma / vestibular schwannoma), a stroke in the posterior circulation, or Ramsay Hunt syndrome (herpes zoster oticus with VZV reactivation in the geniculate ganglion).

Asymmetric Loss Detected on Any Hearing Screen

Unilateral or strongly asymmetric SNHL (greater than 15 dB difference between ears at two or more frequencies) warrants MRI of the internal auditory canals with gadolinium to exclude retrocochlear pathology such as vestibular schwannoma. The prevalence of vestibular schwannoma among patients presenting with asymmetric SNHL is approximately 1 to 2%, which is low in absolute terms but high enough to justify imaging before attributing the loss to aging alone.

Hearing Loss Plus Vertigo

The combination of hearing loss and true rotational vertigo (the room spins) points to inner ear pathology. Acute unilateral vestibulocochlear loss with severe vertigo can represent labyrinthine infarction, a rare but real vascular emergency in patients over 60 with cardiovascular risk factors. Meniere's disease is far more common, but an ischemic etiology must be excluded with imaging.

Gradual Hearing Loss: When to See a Doctor (Non-Emergency)

Not every hearing complaint requires an emergency room. Gradual bilateral high-frequency loss in a 68-year-old with a history of factory work is almost certainly presbycusis plus NIHL. Still, waiting too long for evaluation causes avoidable harm.

Practical Thresholds for Scheduling an Appointment

See your primary care physician or an audiologist within 2 to 4 weeks if you notice any of the following:

• Needing the television volume at a level others find too loud
• Frequently asking people to repeat themselves, especially on the phone
• Difficulty hearing consonants (confusing "s" and "f," "p" and "t")
• Trouble following conversation in background noise despite normal one-on-one hearing
• Tinnitus that has persisted for more than 2 weeks

The U.S. Preventive Services Task Force has concluded that current evidence is insufficient to assess the balance of benefits and harms of screening for hearing loss in older adults, but this does not mean evaluation is unwarranted when symptoms are present. Self-referred audiologic evaluation is appropriate and evidence-based.

Children and Adolescents

Any parent concerned about a child's speech development, school performance, or behavioral changes should request a pediatric audiology evaluation promptly. Congenital or early-onset SNHL that goes undiagnosed beyond age 3 can affect language acquisition permanently. The CDC's Early Hearing Detection and Intervention program recommends newborn hearing screening, with diagnosis by 3 months and intervention by 6 months of age.

How Hearing Loss Is Diagnosed

Diagnosis involves both a clinical history and objective audiometric testing. Knowing the pathway helps patients arrive prepared.

Clinical History and Physical Examination

The evaluating physician or audiologist will ask about onset (sudden vs. Gradual), laterality, associated symptoms, noise exposure history, medication list, family history, and prior ear surgeries or infections. The physical exam includes otoscopy to visualize the ear canal and tympanic membrane and tuning-fork tests (Weber and Rinne) to distinguish conductive from sensorineural loss at the bedside with a 512 Hz fork.

Pure-Tone Audiometry

Pure-tone audiometry is the standard first-line test. The patient responds to tones played through headphones at frequencies from 250 Hz to 8,000 Hz, and the softest audible level at each frequency is plotted on an audiogram. Results are classified as:

• Normal: thresholds <25 dB HL
• Mild loss: 26 to 40 dB HL
• Moderate loss: 41 to 55 dB HL
• Moderately severe: 56 to 70 dB HL
• Severe: 71 to 90 dB HL
• Profound: <90 dB HL (or no measurable response)

Bone conduction testing separates conductive from sensorineural components. Speech audiometry (word recognition scores) adds functional context.

Additional Tests

Tympanometry measures middle ear pressure and tympanic membrane mobility, identifying effusion, negative pressure, or discontinuity of the ossicular chain.

Auditory brainstem response (ABR): A neurophysiologic test used when voluntary audiometry is unreliable (infants, neurologically impaired patients) or when retrocochlear pathology is suspected.

MRI internal auditory canals with gadolinium: The definitive imaging study for vestibular schwannoma and other retrocochlear lesions.

Genetic testing: Recommended for children with SNHL of unclear origin. GJB2 (connexin 26) mutations account for approximately 50% of cases of non-syndromic autosomal recessive SNHL.

Treatment Options for Hearing Loss

Treatment depends entirely on the type, severity, and underlying cause.

Corticosteroids for Sudden SNHL

Oral prednisone at 1 mg/kg/day (maximum 60 mg) tapered over 10 to 14 days remains the standard first-line treatment for SSNHL. Intratympanic dexamethasone (0.4 mL of 24 mg/mL solution injected through the tympanic membrane) is offered as salvage therapy for patients who fail oral steroids or as primary therapy when systemic steroids are contraindicated. A Cochrane systematic review found that intratympanic corticosteroids resulted in significantly better hearing recovery compared to placebo when used as primary treatment, with a mean improvement of 13.4 dB over control.

Hearing Aids

Hearing aids are the mainstay for mild-to-severe bilateral SNHL where the underlying cause cannot be reversed. Modern receiver-in-canal (RIC) and behind-the-ear (BTE) devices use digital signal processing to reduce background noise and provide directional amplification. Over-the-counter hearing aids became available in the U.S. For adults with mild-to-moderate loss following FDA final rule OTC Hearing Aid regulations effective October 17, 2022, lowering cost barriers significantly. Despite this, only about 20% of adults who could benefit from amplification actually use hearing aids, a gap attributed to stigma, cost, and perceived benefit.

Cochlear Implants

Cochlear implants bypass the damaged cochlear hair cells entirely by delivering electrical stimulation directly to the auditory nerve. They are indicated for adults with bilateral severe-to-profound SNHL who receive limited benefit from hearing aids, defined as sentence recognition scores of 50% or less in the best-aided condition. A meta-analysis in JAMA Otolaryngology found that adults implanted within 5 years of severe hearing loss onset achieved significantly better speech perception outcomes than those implanted after longer delays.

Surgical Options

• Stapedectomy or stapedotomy for otosclerosis: hearing restoration in over 90% of cases
• Tympanoplasty for tympanic membrane perforation with conductive loss
• Myringotomy with tube placement for persistent OME with at least 40 dB conductive loss lasting over 3 months

Ototoxicity Management

When ototoxic medications cannot be discontinued (e.g., platinum-based chemotherapy for active cancer), audiologic monitoring every 1 to 2 treatment cycles allows early detection of threshold shift. Sodium thiosulfate has been studied as a cisplatin otoprotectant in pediatric oncology; the ACCL0431 trial (N=125) found that intratympanic sodium thiosulfate reduced the incidence of cisplatin-associated hearing loss by 47% without compromising tumor response.

Noise-Induced Hearing Loss: Prevention Is the Only Cure

NIHL is entirely irreversible and entirely preventable. Cochlear outer hair cells destroyed by acoustic trauma do not regenerate in humans.

The 85 dB / 8-Hour Rule

OSHA's permissible exposure limits set 90 dB as the maximum for an 8-hour workday without hearing protection, with a 5 dB exchange rate (exposure duration must halve for every 5 dB increase). NIOSH uses a stricter 85 dB threshold with a 3 dB exchange rate, meaning 88 dB is safe for only 4 hours and 91 dB for only 2 hours. Common real-world sound levels to contextualize this:

• Normal conversation: 60 dB
• City traffic from inside a car: 80 to 85 dB
• Motorcycle at 25 feet: 90 dB
• Live music at a concert: 94 to 110 dB
• Jet engine at 100 feet: 140 dB (pain threshold)

Hearing Protector Selection

Foam earplugs carry a Noise Reduction Rating (NRR) of 28 to 33 dB when inserted correctly. Earmuffs provide NRR 20 to 30 dB. For concert settings, musician's earplugs (custom-fit with flat attenuation filters) reduce volume uniformly across frequencies, preserving sound quality while protecting cochlear hair cells at a level that standard foam inserts cannot match.

Tinnitus as a Symptom Alongside Hearing Loss

Tinnitus (ringing, buzzing, hissing, or roaring in the ears) frequently accompanies both NIHL and SNHL. About 50 million Americans experience tinnitus, and 20 million report it as burdensome. Tinnitus itself is rarely the primary emergency, but unilateral pulsatile tinnitus (a rhythmic sound synchronous with the heartbeat) can indicate a vascular anomaly including arteriovenous malformation, paraganglioma, or dehiscent jugular bulb and warrants prompt otolaryngology and vascular imaging evaluation.

The Hearing Loss-Dementia Link: Practical Implications

Emerging evidence suggests that treating hearing loss may slow cognitive decline. The ACHIEVE trial (Aging and Cognitive Health Evaluation in Elders, N=977) published in The Lancet in 2023 found that hearing intervention reduced the 3-year rate of cognitive decline by 48% in older adults with elevated dementia risk compared to a control intervention. The Lancet Dementia Commission's 2020 report identified hearing loss as the single largest modifiable risk factor for dementia, accounting for an estimated 8% of attributable risk.

These data make a clinically direct case: fitting hearing aids is not cosmetic. For a 70-year-old with moderate bilateral SNHL and a first-degree family history of Alzheimer's disease, initiating amplification is as medically grounded a decision as prescribing antihypertensives for stage 1 hypertension.